NewAmsterdam Pharma Co N.V.

NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001936258

Other share classesNAMSW

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 15, 20264:30 PM ETSep 14, 2026Davidson Michael H.Chief Executive OfficerPPurchaseOrdinary Shares+10K$22.65+$226.5K792.92K+1.3%SEC
Sep 9, 20264:30 PM ETSep 4, 2026Smither John WDirectorSSaleOrdinary Shares−1.6K$25.32−$40.51K8.76K−15.4%SEC
Aug 25, 20264:30 PM ETAug 24, 2026Kastelein Johannes Jacob PieterChief Scientific OfficerSSaleOrdinary Shares−125K$26.91−$3.36M69.3K−64.3%SEC10b5-1
Jul 22, 20264:05 PM ETJul 20, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−105K$30.3396−$3.19M24.35K−81.2%SEC10b5-1
Jun 24, 2026Jun 22, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−40K$30.204−$1.21M24.35K−62.2%SEC10b5-1
May 27, 2026May 26, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−65K$35.69−$2.32M24.35K−72.7%SEC10b5-1
Mar 12, 2026Mar 11, 2026LANGE LOUIS GDirectorSSaleOrdinary Shares−44.62K$30.4182−$1.36M10.36K−81.2%SEC
Mar 10, 2026Mar 6, 2026LANGE LOUIS GDirectorSSaleOrdinary Shares−28.19K$29.41−$828.95K0−100.0%SEC
Mar 9, 2026Mar 5 – Mar 9, 2026Kastelein Johannes Jacob PieterChief Scientific OfficerSSaleOrdinary Shares−300K$30.3029−$9.09M69.3K−81.2%SEC10b5-1
Mar 2, 2026Mar 2, 2026Davidson Michael H.Chief Executive OfficerSSaleOrdinary Shares−443.71K$33.25−$14.75M174.14K−71.8%SEC
Feb 26, 2026Feb 24 – Feb 26, 2026Davidson Michael H.Chief Executive OfficerSSaleOrdinary Shares−306.29K$34.5261−$10.58M174.14K−63.8%SEC10b5-1
Feb 24, 2026Feb 20, 2026Kastelein Johannes Jacob PieterChief Scientific OfficerSSaleOrdinary Shares−45.48K$35.3114−$1.61M53.5K−45.9%SEC
Jan 29, 2026Jan 27 – Jan 28, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−72.43K$32.2508−$2.34M24.35K−74.8%SEC10b5-1
Jan 27, 2026Jan 23 – Jan 26, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−72.57K$33.2889−$2.42M24.35K−74.9%SEC10b5-1
Jan 22, 2026Jan 20 – Jan 21, 2026Somaiya Mayur IanChief Financial OfficerSSaleOrdinary Shares−100K$32.6062−$3.26M58.38K−63.1%SEC10b5-1
Jan 9, 2026Jan 7, 2026Davidson Michael H.Chief Executive OfficerSSaleOrdinary Shares−11.58K––378.86K−3.0%SEC10b5-1
Jan 7, 2026Jan 5, 2026Kastelein Johannes Jacob PieterChief Scientific OfficerSSaleOrdinary Shares−6K$33.25−$199.5K73.48K−7.5%SEC10b5-1
Jan 7, 2026Jan 5, 2026Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−2.65K$33.25−$88.01K12.35K−17.6%SEC10b5-1
Jan 7, 2026Jan 5, 2026Somaiya Mayur IanChief Financial OfficerSSaleOrdinary Shares−5.12K$33.25−$170.17K32.88K−13.5%SEC10b5-1
Dec 29, 2025Dec 23 – Dec 26, 2025Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−145K$35.8396−$5.2M15K−90.6%SEC10b5-1
Sep 17, 2025Sep 15, 2025Topper James NDirectorPPurchaseOrdinary Shares+660$23.70+$15.64K3.03M0.0%SEC
Sep 10, 2025Sep 8, 2025Topper James NDirectorPPurchaseOrdinary Shares+1.26K$24.99+$31.49K3.03M0.0%SEC
Sep 10, 2025Sep 9, 2025Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−150K$25.8268−$3.87M15K−90.9%SEC
Sep 5, 2025Sep 3, 2025Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−18.07K$25.09−$453.45K15K−54.6%SEC
Aug 27, 2025Aug 25, 2025Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−8.27K$24.86−$205.57K15K−35.5%SEC
Aug 25, 2025Aug 21 – Aug 22, 2025Kastelein Johannes Jacob PieterChief Scientific OfficerSSaleOrdinary Shares−100K$24.7164−$2.47M69.3K−59.1%SEC
Aug 13, 2025Aug 11, 2025Topper James NDirectorPPurchaseOrdinary Shares+471$23.98+$11.29K3.03M0.0%SEC
Jul 17, 2025Jul 15 – Jul 16, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−98.61K$21.2617−$2.1M44K−69.1%SEC10b5-1
Jun 26, 2025Jun 24 – Jun 25, 2025Topper James NDirectorPPurchaseOrdinary Shares+3.78K$18.3733+$69.45K3.03M+0.1%SEC
Jun 18, 2025Jun 16, 2025Topper James NDirectorPPurchaseOrdinary Shares+8.58K$19.50+$167.39K3.02M+0.3%SEC
Jun 18, 2025Jun 16, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−100K$19.2914−$1.93M44K−69.4%SEC10b5-1
May 19, 2025May 15, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−100K––44K−69.4%SEC10b5-1
Apr 17, 2025Apr 15, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−100K––44K−69.4%SEC10b5-1
Mar 28, 2025Mar 26, 2025Topper James NDirectorPPurchaseOrdinary Shares+1.14K$22.49+$25.53K3.01M0.0%SEC
Mar 28, 2025Mar 26, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−16.54K––44K−27.3%SEC
Mar 28, 2025Mar 26, 2025Davidson Michael H.Chief Executive OfficerSSaleOrdinary Shares−12.26K––390.44K−3.0%SEC
Mar 19, 2025Mar 17, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−100K––44K−69.4%SEC10b5-1
Mar 6, 2025Mar 4, 2025Topper James NDirectorPPurchaseOrdinary Shares+4.01K$21.02+$84.19K3.01M+0.1%SEC
Mar 5, 2025Mar 4, 2025Kooij Louise FrederikaChief Accounting OfficerSSaleOrdinary Shares−150K$20.37−$3.06M15K−90.9%SEC
Feb 20, 2025Feb 18 – Feb 19, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−100K––44K−69.4%SEC10b5-1
Jan 31, 2025Jan 29 – Jan 30, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−70.44K––44K−61.6%SEC10b5-1
Jan 29, 2025Jan 27 – Jan 28, 2025Somaiya Mayur IanChief Financial OfficerSSaleOrdinary Shares−61.88K––38K−62.0%SEC10b5-1
Jan 29, 2025Jan 27 – Jan 28, 2025Kling Douglas FChief Operating OfficerSSaleOrdinary Shares−129.56K––44K−74.6%SEC10b5-1
Jan 2, 20254:15 PM ETDec 30, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−29.85K$25.5369−$762.17K10.66M−0.3%SEC10b5-1
Dec 30, 20244:15 PM ETDec 26 – Dec 27, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−74.91K$25.9768−$1.95M10.69M−0.7%SEC10b5-1
Dec 26, 20244:15 PM ETDec 20 – Dec 24, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−91.07K$25.58−$2.33M10.76M−0.8%SEC10b5-1
Dec 20, 20244:25 PM ETDec 18 – Dec 19, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−157.23K$25.8641−$4.07M10.85M−1.4%SEC10b5-1
Dec 18, 20244:15 PM ETDec 16 – Dec 17, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−115.48K$25.9452−$3M11.01M−1.0%SEC10b5-1
Dec 17, 20245:05 PM ETDec 13, 2024BCIP Life Sciences Associates, LP and 9 others10% OwnerPPurchaseOrdinary Shares · Derivative+1.63M$24.4999+$40M1.63M–SEC
Dec 16, 20244:15 PM ETDec 12 – Dec 13, 2024Forbion Capital Fund IV Cooperatief U.A. and 4 others10% OwnerSSaleOrdinary Shares−191.76K$25.3433−$4.86M11.12M−1.7%SEC10b5-1